Panacea Biotec is an Innovation driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals and Vaccines.
Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited with a commitment to make Innovative Products Affordable and Accessible to the masses. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd.
Our aspirations are supported by our Globally accredited USFDA approved pharmaceutical manufacturing facility at Baddi, WHO pre-qualified facilities for vaccine production at Lalru (Punjab) and Baddi.
The international pharmaceutical formulations product portfolio includes highly innovative prescription products in niche therapeutic areas such as Pain, Diabetes & Cardiovascular management, Oncology, Renal Disease, Osteoporosis management and Gastro-intestinal care.
Our first Nanotechnology based product ‘PacliAll’ (Paclitaxel in protein bound particles) was launched in 2011; it was the world’s first generic for Abraxane, manufactured by Celegene USA.
Panacea Biotec has consolidated its presence in about 30 markets across CIS, Latin America, Middle East, Asia & Africa.
Panacea Biotec is one of the largest Vaccine Manufacturing Company in India and is well acknowledged by the United Nations (UN) Health Agencies in partnering the Global Polio Eradication Initiative (GPEI) with supplies of billions of doses of WHO Pre-qualified Polio vaccines in more than 50 countries worldwide as a sequel to the completion of full range of Oral polio vaccines (tOPV, mOPV1, mOPV3 & bOPV (Type1&Type3).
Panacea Biotec is the first company to have developed fully liquid Pentavalent vaccine (DTwP-Hep B+Hib) EasyFive in 2005. EasyFive is a WHO Prequalified vaccine being used in more than 75 countries worldwide as on March 2022.
Panacea Biotec is the first company to have developed World’s first fully-liquid wP-IPV based Hexavalent vaccine (DTwP+HepB+Hib+IPV) EasySix. EasySix was launched in 2017 and millions of doses are produced and supplied in Indian private market.
The other vaccines in portfolio consists of Enivac-HB (Hepatitis B vaccine Paed. & Adult), Ecovac-4 (DTwP+Hep B), Easyfour (DTwP+Hib), EasyFourPol (DTwP-Hib-IPV). Vaccines in development include – recombinanant chimeric Dengue tetravalent, Pneumococcal Conjugate and several others. A strong innovative vaccine pipeline is on the anvil which would pave the way for a consistent introduction of Next Generation Vaccines in future.
DATE AND TIME:
DATE : 11th oct 2025
TIME : 10:00 am -4:30 Pm
VENUE : Panacea Biotec Ltd,Lalru
Interested Candidates may also send their CVs to lakhvirsingh@panaceabiotec.com
CELL:8968775305
JOB DETAILS:
- Department: Production/QC/QA/Engineering
- EXP: Freshers
- Qualification: ITI,Diploma,Bsc,Bpharm,B.tech
- Location: Punjab
For More JOB Updates Join Our Whatsapp Group Click Here
